DyeVert™ PLUS Contrast Reduction System is a dye management solution for patients with at-risk kidney factors, including:
1 Desch, S. A Novel System to Save Contrast During Coronary Angiography – The DyeVertTM Randomized Controlled Trial. Presented abstract at Transcatheter Cardiovascular Therapeutics Annual Meeting, Washington, DC, October 2016.
Indications, contraindications, warnings, and instructions for use can be found in the product labeling supplied with each device. Risks may include air emboli and infection.
CAUTION: Federal (USA) law restricts these devices to sale by or on the order of a physician.
Uncompromised Imaging: Seeing is Believing
Injections into coronary arteries may result in excess reflux into the aorta that is not needed for imaging. DyeVert™ PLUS reduces contrast amount without compromising image quality. See for yourself.